At Philips Nordics, staff members held their breaths, went Scandinavia went into lockdown in spring.
What would happen to the product sales that depended on open clinics and stores? And how would the firm accommodate the massively increased demand for products that can supply oxygen and monitor intensive-care patients?
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Hearing firms urge FDA to increase OTC safety requirements
A number of the world’s biggest hearing aid manufacturers have come together to encourage the US health authority to tighten the safety requirements for OTC hearing aids, which will hit the shelves in the US sometime this year.
Coloplast initiates trial of ostomy leakage product
The medtech company will being clinically testing its ostomy add-on product, Heylo, in January.
Top news from MedWatch this week
Miss anything?
Danish bank cuts Genmab price target, retains "buy" recommendation
Jyske Bank has adjusted its valuation of Genmab’s share price target to DKK 2850 (USD 434.4). Investors should continue to buy, the Danish bank says.
Novo Nordisk launches oral semaglutide in India
Novo Nordisk’s diabetes drug, semaglutide, will be sold in the country in a similar price range as its injectable version.
Medical Director, Translational Medicine 
QA Specialist 
Director Regulatory Affairs 
Lead Scientist, Global STA, Royal DSM/Glycom 
Director Medical Science 
QA Manager GMP/GDP Compliance & Audits 
Senior Manager, Accounting Operations 
Health Economist 
Clinical Research Associate 
GxP QA Compliance Manager for Quality Assurance 
Senior Director, Global Regulatory Lead 
Senior Key Account Manager 
Chemists are wanted for ALK's internal Aircraft Corps